The Menopause

Menopause is a life-stage in which women experience reproductive decline and the time of the last menstrual bleeding triggered by ovulation. Menopause occurs generally between the ages of 45 and 55 years, but varies widely among women. Menopause is a process, with several stages. Perimenopause is the first stage in which estrogen and hormone levels begin to drop and menstrual cycles become irregular. Menopause is the stage in which women do not menstruate for 12 straight months and postmenopause after one year has passed without a menstrual cycle. 

During menopause the follicular phase is shortened, thus causing menstrual cycles overall to shorten. In late perimenopause, shortly before menopause, irregular cycles (sometimes without ovulation) and major irregularities in bleeding occur.

Women who go through menopause with Daysy’s support have the opportunity to know more about themselves and their bodies. They can actively track  this phase of their reproductive journey to better prepare for this new stage of life and actively address changes they may be experiencing.

Demystifying Perimenopause with Daysy

During perimenopause, many women also experience a change of consciousness. Instead of focusing on fertility, there is a shift focusing on  observing their infertility. Of course, Daysy may not be able to predict exactly how your body will progress through this delicate transition, but Daysy can help you understand what’s happening in the moment. It is important to understand what happens in hormone production both prior to menopause and during menopause:

During reproductive age, hormones control the reproductive cycle, which are produced in the brain and ovaries. Under the influence of the follicle-stimulating hormone (FSH), eggs mature in the follicles. These produce oestrogen, which leads to the formation of the lining of the uterus and, at an appropriate level, causes the brain to trigger ovulation.

The remaining corpus luteum produces progesterone, which prepares the lining of the uterus for pregnancy. If this does not occur, progesterone production stops and the lining of the uterus is shed during menstruation. With increasing age, the sensitivity of the ovaries to hormonal stimulation decreases. Ovulation takes place less frequently and the production of oestrogens in the follicles decreases.

Hormones Menopause

During menopause, the number of follicles is about 1000 (for comparison: at the end of puberty, women have about 250,000 germ cells per ovary, which can mature into follicles) (1). After the onset of menopause, hormone levels usually stabilise again within two years. Once this process is complete, very few reproductive hormones can be detected in the body.

Daysy is effective at all stages of your reproductive years

Daysy supports you in recognizing the approach of ovulation and the fertile window with a high degree of accuracy. Similarly, Daysy can also calculate when ovulation has passed and the infertile phase is reached. Thus, irregularities in cycle length do not reduce accuracy, unlike the Calendar (Rhythm) Method, which would no longer be reliable due to the possible irregular cycle length. Daysy's fertility algorithm learns and adapts to each individual cycle. You can continue to effectively achieve your personal reproductive goals by using Daysy throughout perimenopause.

Although this marks the beginning of a new phase of life, menopause comes with both opportunity and complexity. Our bodies are complicated, but they do not have to be mysterious. Using Daysy allows you to learn to recognize your own unique patterns and use that knowledge to live your best life.

Daysy - Your personal fertility tracker (incl. app DaysyDay)
239.00 EUR 299.00 EUR

Until 10/13/2024
incl. VAT and Shipping - Product available - Delivery time: 2-3 days*

Daysy is an intelligent fertility tracker that lets you get to know your very own menstrual cycle.

1) Richardson SJ et al. Follicular depletation during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 1987;65:1231-1237